Dermata Therapeutics, Inc. Common Stock
DRMARank #118Updated . Prices are snapshots and may be delayed.
Dermata Therapeutics, Inc. Common Stock price chart
AI Outlook for Dermata Therapeutics, Inc. Common Stock
Bearish posture- Long-term trend-36.9% vs 200-day average
- Medium-term trend-27.9% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Dermata Therapeutics, Inc. Common Stock performance
About Dermata Therapeutics, Inc. Common Stock
Dermata Therapeutics, Inc. Common Stock is a biotechnology company based in the United States, listed on NASDAQ since 2021 (ticker DRMA).
Its market capitalisation is $3 million, the #118 largest of the 127 stocks Air Radar has market-cap data for.
Dermata Therapeutics, Inc. Common Stock market data
What is the price of Dermata Therapeutics, Inc. Common Stock today?
Dermata Therapeutics, Inc. Common Stock (DRMA) is at $0.91, +18.41% on the day.
What is the 52-week range of Dermata Therapeutics, Inc. Common Stock?
Over the past year Dermata Therapeutics, Inc. Common Stock has traded between $0.6032 and $4.66. It is currently 8% of the way up that range.
What is the market cap of Dermata Therapeutics, Inc. Common Stock?
Dermata Therapeutics, Inc. Common Stock has a market capitalisation of $3,286,789, the #118 largest of the stocks Air Radar has market-cap data for.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.